Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameer A Parikh

Showing results (91-100 of 182) with videos related to

Pageof 19
Sort By:
Cancer|May 2, 2015
Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomesSameer A Parikh, Jose F Leis, Kari G Chaffee, et al.
Leukemia & Lymphoma|November 26, 2016
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL)Tait D Shanafelt, Sameer A Parikh, Peter A Noseworthy, et al.
American Journal of Hematology|March 27, 2026
High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma SubtypesArushi Khurana, Hikaru Hayashi, Bethany Thach, et al.
The Lancet. Haematology|August 30, 2016
Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trialPaolo Strati, Mark Lanasa, Timothy G Call, et al.
British Journal of Haematology|July 16, 2022
Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemiaPaul J Hampel, Kari G Rabe, Timothy G Call, et al.
The American Journal of Surgical Pathology|May 16, 2018
PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal RelatednessRong He, Wei Ding, David S Viswanatha, et al.
Blood Cancer Journal|August 6, 2021
Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic IndexYucai Wang, Sara J Achenbach, Kari G Rabe, et al.
Leukemia & Lymphoma|October 10, 2025
Expert consensus opinion on the management of hairy cell leukemia in elderly patientsTamar Tadmor, Judit Demeter, Andrei Fagarasanu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell LymphocytosisBryan A Vallejo, Ahmed Ansari, Sameer A Parikh, et al.
Blood Advances|March 27, 2024
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemiaPaul J Hampel, Mahesh Swaminathan, Kerry A Rogers, et al.
Pageof 19

Showing results (91-100 of 182) with videos related to

Sort By:
Pageof 19
Cancer|May 2, 2015
Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomesSameer A Parikh, Jose F Leis, Kari G Chaffee, et al.
Leukemia & Lymphoma|November 26, 2016
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL)Tait D Shanafelt, Sameer A Parikh, Peter A Noseworthy, et al.
American Journal of Hematology|March 27, 2026
High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma SubtypesArushi Khurana, Hikaru Hayashi, Bethany Thach, et al.
The Lancet. Haematology|August 30, 2016
Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trialPaolo Strati, Mark Lanasa, Timothy G Call, et al.
British Journal of Haematology|July 16, 2022
Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemiaPaul J Hampel, Kari G Rabe, Timothy G Call, et al.
The American Journal of Surgical Pathology|May 16, 2018
PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal RelatednessRong He, Wei Ding, David S Viswanatha, et al.
Blood Cancer Journal|August 6, 2021
Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic IndexYucai Wang, Sara J Achenbach, Kari G Rabe, et al.
Leukemia & Lymphoma|October 10, 2025
Expert consensus opinion on the management of hairy cell leukemia in elderly patientsTamar Tadmor, Judit Demeter, Andrei Fagarasanu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell LymphocytosisBryan A Vallejo, Ahmed Ansari, Sameer A Parikh, et al.
Blood Advances|March 27, 2024
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemiaPaul J Hampel, Mahesh Swaminathan, Kerry A Rogers, et al.
Pageof 19